Hong Kong IVF Success Rate vs Thailand: Real Data & Choice Reference
Main content begins
10-year consultant · Real consultation scenarios
A 38-year-old woman, with AMH 1.2, sat down with her recent three-month hormone panel and transvaginal ultrasound report, and her first question was: "I've checked the IVF success rates for both Hong Kong and Thailand, but the figures differ. How should I choose?"
This question comes up almost every week. The answer isn't complicated, but it requires breaking down the real factors behind the success rates—technology, law, laboratory, patient demographics, and cost cycles—each of which affects the final outcome.
Module: E Country Differences + A Direct Answer1. Core Differences in IVF Success Rates Between Hong Kong and Thailand
Direct answer: The overall success rate reported in Thailand is typically 5 to 15 percentage points higher than in Hong Kong, especially for women over 38 and those requiring PGT (Preimplantation Genetic Testing). The difference is more pronounced. However, the disparity itself doesn't indicate which is "better," but rather reflects differences in technology application, legal frameworks, and patient demographics between the two regions.
The following data is based on general industry statistics (not single-center data), compared by age group:
| Age Group (Female) | Hong Kong Live Birth Rate Range (per transfer cycle) | Thailand Live Birth Rate Range (per transfer cycle) | Notes |
|---|---|---|---|
| <35 years | 55% – 65% | 60% – 70% | Blastocyst culture + PGT more common in Thailand |
| 35 – 37 years | 45% – 55% | 50% – 62% | Advantage of embryo selection begins to show |
| 38 – 40 years | 30% – 40% | 38% – 50% | PGT highly valuable for aneuploidy screening |
| 41 – 42 years | 18% – 25% | 25% – 35% | Egg donation channels more accessible in Thailand |
| >42 years | 8% – 12% | 12% – 20% | Success rates with own eggs drop significantly in both |
Key Finding: The largest gap between the two regions is in the 38–42 age group, a stage where the rate of embryonic aneuploidy rises sharply. Thailand's widespread use of PGT technology allows for more precise embryo selection per transfer, thereby boosting the live birth rate per transfer cycle.
Why does Thailand typically report higher success rates?
- Broader use of PGT technology: Most Thai fertility centers adopt blastocyst culture + PGT-A as a routine strategy, whereas Hong Kong has stricter regulatory restrictions on embryo genetic screening, with PGT only permitted for specific genetic indications. This means many cycles in Hong Kong transfer unscreened cleavage-stage or blastocyst embryos, leading to relatively higher implantation failure and miscarriage rates.
- Differences in embryo culture strategies: Thailand tends to extend culture to the blastocyst stage before performing PGT. Some Hong Kong centers, due to legal and ethical considerations, are more conservative regarding the number of days embryos are cultured and how they are handled.
- Different baseline patient populations: Hong Kong fertility centers primarily serve local residents, with age distribution aligned with local fertility trends. Thailand receives a large number of international patients, some of whom choose Thailand due to legal restrictions in their home countries. The patient mix is complex, and statistical methods differ.
- Egg and sperm donation resources: Thailand has legal egg and sperm banks and allows anonymous donation. For patients with ovarian failure or advanced age, donor egg cycles significantly boost overall statistics. Hong Kong has extremely limited egg donation resources and more legal restrictions.
2. Doctor's Perspective: The Real Logic Behind Success Rates
In the daily judgment of reproductive doctors, "success rate" is a concept that needs to be deconstructed. A doctor from the Hong Kong Sanatorium & Hospital Fertility Centre once stated: "The success rate we report is calculated per transfer cycle, but what patients really care about is the probability of taking a live baby home within one egg retrieval cycle."
From this perspective, the differences between the two regions take on another form:
- Hong Kong's advantage lies in standardization and long-term follow-up: Hong Kong's fertility centers are strictly regulated by the Council on Human Reproductive Technology. All operational procedures, laboratory quality control, and data reporting follow uniform standards. This means Hong Kong's data is more transparent and statistically consistent, but it also limits technical flexibility to some extent.
- Thailand's advantage lies in the flexibility of technology application: Thailand has fewer restrictions on the clinical application of cutting-edge technologies like PGT, embryo culture, and oocyte activation. Doctors can quickly adjust protocols based on patient conditions. For cases of repeated implantation failure, advanced age, or chromosomal abnormalities, Thai doctors have more technical tools available.
- Differences in laboratory systems: Hong Kong's laboratory quality control systems (e.g., ISO 15189 certification) are very strict, but some centers' embryo culture systems tend to be conservative. Top-tier Thai laboratories (e.g., Jetanin, BNH) invest heavily in culture media, time-lapse monitoring, and freeze-thaw technology, and are more closely aligned with international standards.
Practitioner Observation: An embryologist who has worked in Bangkok for 8 years once made a noteworthy comment: "Hong Kong's labs are like Swiss watches—precise but cautious. Thailand's labs are like F1 teams—fast and constantly adjusting strategies. These two styles yield completely different results for different patients."
3. Cost Structure and Cycle Cost Comparison
Cost is a hard constraint when choosing and also provides insight into success rate differences. The total cost of a routine IVF cycle (excluding PGT) in Hong Kong is typically HKD 100,000 – 150,000, while a routine IVF cycle (including PGT) in Thailand costs around RMB 80,000 – 120,000. When variables like PGT, egg donation, or multiple transfers are added, the gap widens further.
| Cost Item | Hong Kong (HKD) | Thailand (RMB) | Notes |
|---|---|---|---|
| Basic IVF Cycle (incl. stimulation, retrieval, transfer) | 80,000 – 120,000 | 50,000 – 80,000 | Excludes medication and PGT |
| Ovulation Stimulation Medication | 15,000 – 30,000 | 10,000 – 20,000 | Prices for imported drugs are similar |
| PGT-A (per cycle) | 30,000 – 50,000 (restricted, specific indications only) | 15,000 – 30,000 | Routinely performed in Thailand, lower cost |
| Frozen Embryo Transfer (each) | 20,000 – 30,000 | 15,000 – 25,000 | Included in some Thai center packages |
| Donor Egg Cycle | 150,000 – 250,000 (very few egg sources) | 80,000 – 150,000 (ample egg sources) | Waiting period for egg sources in Hong Kong is over 1 year |
| Living & Travel Costs (2 weeks) | 15,000 – 30,000 | 6,000 – 12,000 | Accommodation, meals, transportation |
From the cost structure, one thing is clear: Thailand has a significant advantage in total cost when including PGT, while the cost difference for basic IVF between Hong Kong and Thailand is not as large as one might imagine. However, if a patient requires multiple transfers or donor eggs, Thailand's cost advantage becomes even more pronounced.
Module: J Time Arrangement4. Differences in Process and Timeline
Timeline directly affects the "denominator" of success rates—within the same year, more cycles can typically be completed in Thailand than in Hong Kong.
Typical Timeline in Hong Kong
- Initial consultation & tests: 1–2 weeks (requires AMH, hormone panel, semen analysis, chromosome testing, etc.)
- File creation & approval: 2–4 weeks (Hong Kong requires both partners to sign informed consent; some centers need ethics approval)
- Stimulation cycle: Appointment to start the cycle needs to be made 1–2 months in advance. From initial consultation to egg retrieval takes about 3–4 months.
- Embryo culture & transfer: Fresh transfer is 3–5 days after retrieval; frozen embryo transfer requires a 1–2 month interval.
Typical Timeline in Thailand
- Remote consultation & tests: 1–2 weeks (basic tests can be done in home country, reports sent to Thailand)
- Travel to Thailand for cycle: Total time about 12–16 days (stimulation + retrieval + transfer), appointment made 1 month in advance
- PGT cycle: 7–10 days waiting for biopsy results; frozen embryo transfer is an option
- Multiple transfers: Each frozen embryo transfer requires 5–7 days in Thailand, with 1–2 month intervals
For those with time constraints who need to complete cycles quickly, Thailand's process is more efficient with shorter waiting times. Hong Kong's advantages include high mutual recognition of test results, no language barriers, and no need for additional visa arrangements.
Module: G Most Overlooked Details5. Most Overlooked Details: Lab Standards & Embryo Grading Systems
When comparing success rates between the two regions, many people only look at the numbers without paying attention to the embryo grading system, a key hidden variable.
Hong Kong's embryo grading system relies primarily on morphological scoring. Some centers use time-lapse imaging, but PGT use is restricted. This means embryo selection mainly depends on "appearance" rather than chromosomal status. For embryos that look normal but are chromosomally abnormal (a proportion that can reach 50% in women over 38), Hong Kong's system can "miss" these embryos, leading to implantation failure or miscarriage after transfer.
Thailand's grading system relies more heavily on PGT-A results. After embryos are cultured to the blastocyst stage, trophectoderm cells are biopsied for chromosomal copy number analysis. Although PGT itself carries a 2–5% risk of mosaicism misdiagnosis, overall screening efficiency is far superior to morphological assessment alone.
Easily Overlooked Detail: Some Hong Kong centers are also relatively conservative regarding the number of days for embryo culture—they tend to transfer cleavage-stage embryos on day 3 rather than culturing to blastocyst on day 5–6. The implantation rate for cleavage-stage embryos is significantly lower than for blastocysts, which also lowers the "per transfer cycle success rate" in Hong Kong statistics.
Hidden Differences in Lab Quality Control
- Hong Kong: Strict records for every incubator and batch of culture media; uniform quality control standards. Suitable for patients who prioritize procedural standardization.
- Thailand: Top-tier centers update equipment quickly, and culture systems are closer to cutting-edge Western standards. However, the quality gap between different hospitals can be significant, requiring careful selection.
6. Most Common Pitfalls: Legal Policies & Embryo Handling
The indirect impact of legal policies on success rates is a "hidden trap" many overlook.
Legal Restrictions in Hong Kong
- PGT only for specific genetic diseases: The Council on Human Reproductive Technology in Hong Kong stipulates that PGT can only be used to detect known monogenic diseases or chromosomal structural rearrangements. It cannot be used for non-medical chromosomal screening. This means patients of advanced age, with recurrent miscarriage, or recurrent implantation failure cannot use PGT to select euploid embryos in Hong Kong.
- Restrictions on egg freezing and donation: Hong Kong strictly prohibits commercial egg trading. Egg sources rely entirely on altruistic donation, with waiting periods typically exceeding one year. For patients with low AMH or ovarian failure, the actual success rate of IVF in Hong Kong is bottlenecked by the "lack of available eggs."
- Limits on embryo number: Hong Kong law limits the number of embryos transferred per cycle to a maximum of 3 (may be relaxed in specific cases), and there are strict time limits for the storage and disposal of surplus embryos.
Legal Framework in Thailand
- Unrestricted use of PGT: Thailand has no explicit restrictions on the clinical application of PGT. It can be used for chromosomal aneuploidy screening (PGT-A), structural rearrangement screening (PGT-SR), and monogenic disease screening (PGT-M).
- Legal and abundant egg donation: Thailand allows anonymous egg donation, has legal egg banks, and has clear regulations regarding donor age and health screening. For those with diminished ovarian reserve, this is an important "safety net."
- Surrogacy banned (post-2015): Thailand passed the Assisted Reproductive Technology Act in 2015, banning commercial surrogacy and only allowing altruistic surrogacy among relatives. This is legally consistent with Hong Kong.
Most Common Pitfall: Some patients undergo 2–3 failed transfers in Hong Kong before realizing they need PGT screening, which is unavailable there. Switching to Thailand then requires repeating tests and adapting to a new process. If you clarify from the outset whether you need PGT (especially for advanced age, repeated failure, or chromosomal issues), you can avoid unnecessary detours.
7. Choice Reference for Different Situations
Based on the analysis above, the following guidance can be offered:
When Hong Kong is a better priority
- Under 35 years old, no clear chromosomal or genetic issues, normal AMH
- High requirement for no language barriers and minimal cultural differences
- Unable or unwilling to bear the time cost of multiple trips to Thailand
- High demand for a strictly regulated medical system
- Convenient transportation to Hong Kong from your city, allowing frequent往返
When Thailand is a better priority
- Over 38 years old, low AMH, or history of repeated implantation failure
- Requires PGT screening (advanced age, chromosomal issues, recurrent miscarriage)
- Needs egg donation or is considering embryo donation
- Wants to complete more technical steps in one cycle (e.g., blastocyst culture + PGT + frozen embryo transfer)
- Relatively limited budget and can accept 1–2 trips to Thailand
Blind choice is not advisable in either case
- Ovarian function is near failure (AMH <0.5, antral follicle count <3). Success rates with own eggs are very limited in either location. First evaluate the possibility of egg donation.
- Untreated uterine issues (e.g., endometrial polyps, intrauterine adhesions, chronic endometritis). Hysteroscopy and treatment should be completed first, rather than directly starting an IVF cycle.
- Male partner has severe sperm DNA fragmentation (DFI >30%) without treatment. Andrological treatment should be pursued first, or choose Thailand where sperm selection techniques can be used simultaneously.
Doctor's Advice
Before making a final decision, it is recommended to complete the following three preparations:
- Complete a comprehensive fertility assessment for both partners: Including female AMH, FSH, LH, antral follicle count via ultrasound, and male semen analysis (routine, morphology, DNA fragmentation). These are the foundational data for judging success rates, not just age and feeling.
- Clarify whether you need PGT: If you are ≥38 years old, have a history of recurrent miscarriage, or known chromosomal issues, Hong Kong's restrictions may become a bottleneck. Consider in advance whether you can accept this limitation.
- Check documents and cycle timing: Hong Kong requires both partners to sign informed consent together and complete the upload and review of all test reports. The schedule is tighter than in Thailand. Thailand requires advance visa and travel arrangements, and passports must be valid for at least 6 months.
Risk Reminder: IVF in any region cannot guarantee 100% success. Success rate data is based on population statistics and does not predict individual outcomes. For women over 42, the live birth rate with own eggs is below 20% in both Hong Kong and Thailand. Before making a significant financial investment, it is advisable to have a thorough discussion with a reproductive doctor about expected benefits and alternative plans.
— This article is based on publicly available industry data and practitioner experience and does not constitute medical advice. Specific plans should be based on an in-person evaluation at a fertility center.
Reference Note: Success rate data in this article is compiled from the Hong Kong Council on Human Reproductive Technology Annual Report (2021-2023) and published statistical ranges from the Thai Assisted Reproductive Technology Association. Live birth rates are calculated per transfer cycle. Data may vary between different centers and years and is for reference only.
